# Moonwalk Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/moonwalk-biosciences

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.moonwalk.bio
- Total disclosed funding: $120M
- Latest round: Series B (Sep 8, 2026)
- Investors on record: 8

## About

Established in 2022 and based in California, US, Moonwalk Biosciences, Inc. operates as a biotechnology and life science company that develops epigenetic medicines to target complex diseases. The company was founded by its CEO, Alex Aravinas, CTO Arash Jamshidi, COO Justin Valley, and Feng Zhang. In September 2026, Moonwalk Biosciences, Inc. raised USD 70 million in series B funding co-led by Alpha Wave Global and YK Bioventures, with participation from ARCH Venture Partners, Khosla Ventures, and Future Ventures, Eli Lilly & Company, and Gaorong Ventures.

Moonwalk Biosciences provides an epigenetic discovery platform, which is an epigenetic profiling and engineering technology platform that develops therapeutics for complex diseases. The company’s intelligence-based platform analyzes vast amounts of biological data to identify key epigenetic targets for disease intervention. In addition, the firm offers epigenetic editing and clinical product development solutions.

The company plans to use the September 2026 funding to advance its lead obesity drug candidate MW101 into clinical trials, expand its adipose-targeted siRNA pipeline, and further develop its RNAi discovery platform.

## Funding rounds

- Series B, Sep 8, 2026, $70M — ARCH Venture Partners, Khosla Ventures, Alpha Wave Global, Eli Lilly & Company, Gaorong Ventures, Future Ventures, YK Bioventures
- Seed, Dec 18, 2023, $50M — ARCH Venture Partners, Khosla Ventures, GV, Alpha Wave Global, Future Ventures, YK Bioventures

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Seed, Series B
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed, Series B
- GV (https://capitalatlas.ai/funds/gv) — Seed
- Alpha Wave Global (https://capitalatlas.ai/funds/alpha-wave-global) — Seed, Series B
- Future Ventures — Seed, Series B
- YK Bioventures (https://capitalatlas.ai/funds/yk-bioventures) — Seed, Series B
- Eli Lilly & Company — Series B
- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Series B